BioSpace News Archive

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

InterVenn Biosciences today announced that company management will participate at the following virtual investor conferences: Stifel 2021 Virtual Healthcare Conference Formal presentation on Tuesday, November 16, 2021 at 11:00 a.m. PT / 2:00 p.m. ET

Rallybio Corporation today announced that company management will participate in a pre-recorded fireside chat at the Jefferies London Healthcare Conference. Rallybio will also host one-on-one meetings on Thursday, November 18, 2021.

UroGen Pharma Ltd. today announced that it will present at the following virtual healthcare conferences in November: Stifel 2021 Virtual Healthcare Conference

Pieris Pharmaceuticals, Inc., a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer, and other indications, announced that members of the management team will participate in the following upcoming investor conferences:

Better Therapeutics, Inc. today announced the appointment of Major General Elder Granger, M.D., U.S. Army (retired) to its board of directors.

enVVeno Medical Corporation, a company setting new standards of care for the treatment of venous disease, reported its financial results for the quarter ended September 30, 2021.

Pressure BioSciences, Inc., a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialized services to the worldwide life sciences, agriculture, cosmetics, food & beverage, and other industries, announced the award of its second U.S. patent for its revolutionary Ultra Shear Technology™ platform.

StageZero Life Sciences, Ltd., a vertically integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge molecular diagnostics and clinical interventions, announced its support for Teen Cancer America to improve detection and treatment of cancer in adolescents and young adults.

Vericel Corporation today announced that Nick Colangelo, President and CEO, will present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum on Thursday November 18th , at 10:00a.m. Eastern Time.